Press release
UTI Drugs Market 2018 |New Business Opportunities and Investment | Most Eminent Players- Bayer AG, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Cipla Inc.
UTI Drugs Market -Highlights
UTI drugs are used for the treatment of urinary tract infection caused by bacterial or fungal infections. World Health Organization (WHO) estimates that approximately 50 % of women have UTI at some point in their lives resulting in more than $1 million hospitalizations per year.
WHO estimates the cost of UTI infections to be annually greater than $1 billion? It has further been stated that chances of boys being diagnosed with UTI is 1% while chances of girls being diagnosed with UTI is 3 to 8%.
Access Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2540
On the other hand market constraints includes excellent efficacy of present antibiotics specially quinolones, growing drug resistance, unmet clinical needs, increasing incidence of chronic diseases etc. However, the rise of drug resistance has created the need for novel acting antibiotic.
The future of UTI treatment seems to be development of biologics with greater market development especially with respect to poorly growing African market. The loss of patents, weakening developed pipelines and poor expenditure on health in African region had further constrained the market growth.
UTI Drugs Market -Key Players
Bayer AG
Novartis AG
Pfizer Inc.
F. Hoffmann-La Roche Ltd
AstraZeneca
Cipla Inc.
Dr. Reddy’s Laboratories Ltd.
UTI Drugs Market -Segmentation
The Middle East and Africa UTI drugs market has been segmented into drug class which includes quinolones, aminoglycosides, β-lactam, azoles and others. Among all these drug classes quinolones have the largest market value due to their broad variety and excellent efficacy. The share of aminoglycosides have been reduced by a small margin as this drug is resistance.
For Detailed Reading Visit @ https://www.marketresearchfuture.com/reports/mea-uti-drugs-market-2540
Thus the current trend in UTI treatment is combined drug regimen. The market threat includes a form of substandard, counterfeit and spurious drugs have emerged. However it has to be noted that a huge unmet need exists for these drugs in the Middle East and African region.
UTI Drugs Market -Regional Analysis
Depending on geographic region, UTI drugs market is segmented into following countries: UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman; UAE is the largest market followed by Egypt. However the future market will be led by poorly developed parts of Africa due to large unmet needs.
Middle East and Africa UTI Drugs market:
The Middle East and Africa UTI drugs market has been evaluated to be growing market and is expected that the market will grow moderately in the future. The Middle East and Africa UTI drugs market is expected to grow with the CAGR of 4.35% during the forecast period. The growth will primary be led by unmet medical needs and rising incomes of the population.
Major Points form TOC for UTI Drugs Market Research Report – Forecast to 2023
1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
…TOC Continued
Get Excusive Discount @ https://www.marketresearchfuture.com/check-discount/2540
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release UTI Drugs Market 2018 |New Business Opportunities and Investment | Most Eminent Players- Bayer AG, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Cipla Inc. here
News-ID: 1285687 • Views: …
More Releases from Market Research Future
Subsea Manifolds Market Projection: USD 4,120.53 Million in 2025 Rising to USD 6 …
The subsea manifolds market plays a critical role in modern offshore oil and gas production by enabling efficient control, distribution, and monitoring of hydrocarbons on the seabed. Subsea manifolds act as gathering points that connect multiple wells to production systems, allowing operators to optimize flow management, reduce infrastructure complexity, and improve overall field performance. As offshore exploration moves into deeper waters and more technically challenging environments, subsea manifolds have become…
Military Cybersecurity Market 2026: Innovation, AI Defense, and Strategic Demand
In an era defined by rapidly evolving cyber threats and digital warfare, the Military Cybersecurity industry is undergoing a fundamental transformation. As nation-states, defense organizations, and allied forces expand their reliance on digital networks, unmanned systems, IoT-enabled platforms, and cloud infrastructures, securing military cyberspace has become a strategic priority. The shifting threat landscape is driving unprecedented demand for advanced cybersecurity solutions that can protect critical defense assets, ensure operational continuity,…
Drone Identification Market Thriving Worldwide industry with AI by 78.23 USD Bil …
The Drone Identification Market is gaining significant traction in 2026 as unmanned aerial systems (UAS) become more widespread across commercial, governmental, and recreational applications. With drone usage expanding rapidly, there is a pressing need for effective identification, tracking, and management systems that ensure airspace safety, regulatory compliance, and coordinated operations. This demand is driving investment in advanced technologies and solutions that support remote identification, situational awareness, and secure communications within…
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CA …
The Healthcare BPO (Business Process Outsourcing) Market is experiencing significant growth as healthcare providers increasingly outsource non-core functions to specialized service providers. Healthcare BPO services include medical billing and coding, claims processing, customer care, revenue cycle management, IT support, telehealth support, transcription services, and other administrative functions. Outsourcing enables healthcare organizations to reduce operational costs, improve process efficiency, and focus on core clinical services.
Market Overview and Growth Trends
As per Market…
More Releases for UTI
Urinary Tract Infection (UTI) Treatment Market Expanding Solutions for Rising Gl …
Introduction
The urinary tract infection (UTI) treatment market is witnessing significant growth, driven by the increasing prevalence of UTIs globally, rising awareness of treatment options, and advances in medical technologies. UTIs affect millions of individuals each year, with women being disproportionately impacted. As antibiotic resistance becomes an increasing concern and healthcare providers explore alternative solutions, the market for UTI treatments continues to evolve.
This article explores the key factors driving the…
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Growing Demand for …
Introduction
Urinary tract infections (UTIs) are among the most common bacterial infections affecting individuals worldwide, especially women. They occur when harmful bacteria enter the urinary tract, leading to inflammation and discomfort. While most UTIs are uncomplicated, meaning they are limited to the lower urinary tract (bladder and urethra), their frequency and impact on daily life highlight the importance of effective treatments. The UTI treatment market is experiencing significant growth, driven by…
Retail Logistics Market Worth Observing Growth | Panalpina, Exel, UTi Worldwide
The latest launched report on Global Retail Logistics Market delivers a transformation framework to understand how megatrends affect industry growth, taking into account the major disrupting forces creating uncertainties for every organisation in the Retail Logistics. Based on these outcomes, HTF MI outline plan for these volatile scenarios considering companies such as APL Logistics, Schneider National, Maersk Logistics, SembCorp Logistics (USA), Panalpina, Exel, UTi Worldwide, Kuehne + Nagel International, DHL…
Investigation for Investors in shares of Patterson-UTI Energy, Inc. (NASDAQ: PTE …
An investigation was announced concnering potential breaches of fiduciary duties by certain directors at Patterson-UTI Energy, Inc.
Investors who purchased shares of Patterson-UTI Energy, Inc. (NASDAQ: PTEN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Patterson-UTI Energy directors breached their fiduciary duties and caused damage to the company and its shareholders.
Houston, TX based Patterson-UTI…
UTI Treatment Market Therapeutic Assessment 2018-2023
Global and Chinese UTI Treatment Industry, 2018 Market Research Report:
The 'Global and Chinese UTI Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global UTI Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the UTI Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals…
Prevalence of Complicated Urinary Tract Infection (UTI) to Increase Globally
Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients. FMI’s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tract…
